Taurus Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-3,367
| Closed | -$225K | – | 95 |
|
|
2021
Q2 | $225K | Sell |
3,367
-498
| -13% | -$32.5K | 0.02% | 94 |
|
|
2021
Q1 | $244K | Sell |
3,865
-452
| -10% | -$28.1K | 0.03% | 80 |
|
|
2020
Q4 | $268K | Hold |
4,317
| – | – | 0.03% | 77 |
|
|
2020
Q3 | $260K | Sell |
4,317
-730
| -14% | -$43.9K | 0.03% | 79 |
|
|
2020
Q2 | $297K | Sell |
5,047
-1
| -0% | -$60 | 0.04% | 74 |
|
|
2020
Q1 | $281K | Hold |
5,048
| – | – | 0.05% | 74 |
|
|
2019
Q4 | $324K | Sell |
5,048
-800
| -14% | -$45.8K | 0.04% | 78 |
|
|
2019
Q3 | $297K | Hold |
5,848
| – | – | 0.04% | 76 |
|
|
2019
Q2 | $265K | Hold |
5,848
| – | – | 0.04% | 81 |
|
|
2019
Q1 | $279K | Sell |
5,848
-200
| -3% | -$9.96K | 0.04% | 81 |
|
|
2018
Q4 | $314K | Hold |
6,048
| – | – | 0.05% | 74 |
|
|
2018
Q3 | $375K | Hold |
6,048
| – | – | 0.05% | 76 |
|
|
2018
Q2 | $335K | Hold |
6,048
| – | – | 0.05% | 77 |
|
|
2018
Q1 | $383K | Hold |
6,048
| – | – | 0.06% | 78 |
|
|
2017
Q4 | $371K | Buy |
6,048
+2,600
| +75% | +$163K | 0.05% | 77 |
|
|
2017
Q3 | $220K | Buy |
+3,448
| New | +$201K | 0.03% | 93 |
|
|
2017
Q2 | – | Sell |
-115,060
| Closed | -$6.26M | – | 99 |
|
|
2017
Q1 | $6.26M | Buy |
115,060
+150
| +0.1% | +$8.23K | 1.03% | 44 |
|
|
2016
Q4 | $6.71M | Sell |
114,910
-4,450
| -4% | -$243K | 1.22% | 36 |
|
|
2016
Q3 | $6.44M | Buy |
119,360
+112,510
| +1,642% | +$7.23M | 1.16% | 40 |
|
|
2016
Q2 | $504K | Hold |
6,850
| – | – | 0.09% | 67 |
|
|
2016
Q1 | $438K | Hold |
6,850
| – | – | 0.08% | 71 |
|
|
2015
Q4 | $471K | Hold |
6,850
| – | – | 0.09% | 69 |
|
|
2015
Q3 | $406K | Hold |
6,850
| – | – | 0.08% | 75 |
|
|
2015
Q2 | $456K | Hold |
6,850
| – | – | 0.08% | 75 |
|
|
2015
Q1 | $442K | Hold |
6,850
| – | – | 0.08% | 74 |
|
|
2014
Q4 | $404K | Hold |
6,850
| – | – | 0.07% | 80 |
|
|
2014
Q3 | $351K | Hold |
6,850
| – | – | 0.07% | 86 |
|
|
2014
Q2 | $332K | Sell |
6,850
-2,000
| -23% | -$98.6K | 0.06% | 89 |
|
|
2014
Q1 | $460K | Buy |
8,850
+2,807
| +46% | +$149K | 0.1% | 82 |
|
|
2013
Q4 | $321K | Hold |
6,043
| – | – | 0.07% | 91 |
|
|
2013
Q3 | $280K | Hold |
6,043
| – | – | 0.06% | 89 |
|
|
2013
Q2 | $270K | Buy |
+6,043
| New | +$262K | 0.06% | 93 |
|
Other funds holding BMY
Taurus Asset Management's BMY Position: Q3 2021 in Review
Taurus Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2021, closing a stake of 3,367 shares — an estimated $225K sold.
Taurus Asset Management first reported a position in BMY in Q2 2013 and held it in 32 quarters. The position peaked at $6.71M in Q4 2016. 2,294 funds tracked by Wall St. Rank hold BMY as of Q3 2021.
- Taurus Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2021 after selling out during the quarter.
- Taurus Asset Management sold 3,367 Bristol-Myers Squibb shares in Q3 2021, an estimated $225K.
- Taurus Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 32 quarters.
- Taurus Asset Management's Bristol-Myers Squibb position peaked at $6.71M in Q4 2016.
- 2,294 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.
Based on Taurus Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.